Global Artificial Intelligence in Epidemiology Market Growth (Status and Outlook) 2022-2028
- Category: Internet & Telecom
- Published Date: Nov 2022
- Publisher: LP Information
- Pages: 123
The global market for Artificial Intelligence in Epidemiology is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Artificial Intelligence in Epidemiology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Artificial Intelligence in Epidemiology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Artificial Intelligence in Epidemiology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Artificial Intelligence in Epidemiology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Artificial Intelligence in Epidemiology players cover Abbott Informatics, AdvancedMD, Agilent Technologies, Allscripts Healthcare and Athenahealth, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Artificial Intelligence in Epidemiology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Artificial Intelligence in Epidemiology market, with both quantitative and qualitative data, to help readers understand how the Artificial Intelligence in Epidemiology market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Artificial Intelligence in Epidemiology market and forecasts the market size by Type (Hardware Technology and Software Technology,), by Application (Disease and Syndromic Surveillance, Infection Prediction and Forecasting, Immunization Information Systems and Public Sentiment Analysis), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Hardware Technology
Software Technology
Segmentation by application
Disease and Syndromic Surveillance
Infection Prediction and Forecasting
Immunization Information Systems
Public Sentiment Analysis
Environmental Impact Analysis
Drug Discovery, Safety, and Risk Analysis
Monitoring Population and Incidence
Knowledge Representation and Mass Notification
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott Informatics
AdvancedMD
Agilent Technologies
Allscripts Healthcare
Athenahealth
Autoscribe Informatics
Cerner Corporation
Change Healthcare
Cognizant
CPSI
CureMD Healthcare
eClinicalWorks
e-Mds Inc.
Epic Systems
GE Healthcare
Google
Graphcore
Greenway Health
IBM
Intel
InterSystems
Kareo
Medhost
Meditech
Medtronic
Micron Technology
Microsoft
NextGen Healthcare
Nvidia
Optum Inc.
Chapter Introduction
Chapter 1: Scope of Artificial Intelligence in Epidemiology, Research Methodology, etc.
Chapter 2: Executive Summary, global Artificial Intelligence in Epidemiology market size and CAGR, Artificial Intelligence in Epidemiology market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Artificial Intelligence in Epidemiology revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Artificial Intelligence in Epidemiology revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Artificial Intelligence in Epidemiology market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Abbott Informatics, AdvancedMD, Agilent Technologies, Allscripts Healthcare, Athenahealth, Autoscribe Informatics, Cerner Corporation, Change Healthcare and Cognizant, etc.
Chapter 14: Research Findings and Conclusion
The APAC Artificial Intelligence in Epidemiology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Artificial Intelligence in Epidemiology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Artificial Intelligence in Epidemiology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Artificial Intelligence in Epidemiology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Artificial Intelligence in Epidemiology players cover Abbott Informatics, AdvancedMD, Agilent Technologies, Allscripts Healthcare and Athenahealth, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Artificial Intelligence in Epidemiology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Artificial Intelligence in Epidemiology market, with both quantitative and qualitative data, to help readers understand how the Artificial Intelligence in Epidemiology market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Artificial Intelligence in Epidemiology market and forecasts the market size by Type (Hardware Technology and Software Technology,), by Application (Disease and Syndromic Surveillance, Infection Prediction and Forecasting, Immunization Information Systems and Public Sentiment Analysis), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Hardware Technology
Software Technology
Segmentation by application
Disease and Syndromic Surveillance
Infection Prediction and Forecasting
Immunization Information Systems
Public Sentiment Analysis
Environmental Impact Analysis
Drug Discovery, Safety, and Risk Analysis
Monitoring Population and Incidence
Knowledge Representation and Mass Notification
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott Informatics
AdvancedMD
Agilent Technologies
Allscripts Healthcare
Athenahealth
Autoscribe Informatics
Cerner Corporation
Change Healthcare
Cognizant
CPSI
CureMD Healthcare
eClinicalWorks
e-Mds Inc.
Epic Systems
GE Healthcare
Graphcore
Greenway Health
IBM
Intel
InterSystems
Kareo
Medhost
Meditech
Medtronic
Micron Technology
Microsoft
NextGen Healthcare
Nvidia
Optum Inc.
Chapter Introduction
Chapter 1: Scope of Artificial Intelligence in Epidemiology, Research Methodology, etc.
Chapter 2: Executive Summary, global Artificial Intelligence in Epidemiology market size and CAGR, Artificial Intelligence in Epidemiology market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Artificial Intelligence in Epidemiology revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Artificial Intelligence in Epidemiology revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Artificial Intelligence in Epidemiology market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Abbott Informatics, AdvancedMD, Agilent Technologies, Allscripts Healthcare, Athenahealth, Autoscribe Informatics, Cerner Corporation, Change Healthcare and Cognizant, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Intelligence in Epidemiology Market Size 2017-2028
2.1.2 Artificial Intelligence in Epidemiology Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Artificial Intelligence in Epidemiology Segment by Type
2.2.1 Hardware Technology
2.2.2 Software Technology
2.3 Artificial Intelligence in Epidemiology Market Size by Type
2.3.1 Artificial Intelligence in Epidemiology Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Artificial Intelligence in Epidemiology Market Size Market Share by Type (2017-2022)
2.4 Artificial Intelligence in Epidemiology Segment by Application
2.4.1 Disease and Syndromic Surveillance
2.4.2 Infection Prediction and Forecasting
2.4.3 Immunization Information Systems
2.4.4 Public Sentiment Analysis
2.4.5 Environmental Impact Analysis
2.4.6 Drug Discovery, Safety, and Risk Analysis
2.4.7 Monitoring Population and Incidence
2.4.8 Knowledge Representation and Mass Notification
2.5 Artificial Intelligence in Epidemiology Market Size by Application
2.5.1 Artificial Intelligence in Epidemiology Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Artificial Intelligence in Epidemiology Market Size Market Share by Application (2017-2022)
3 Artificial Intelligence in Epidemiology Market Size by Player
3.1 Artificial Intelligence in Epidemiology Market Size Market Share by Players
3.1.1 Global Artificial Intelligence in Epidemiology Revenue by Players (2020-2022)
3.1.2 Global Artificial Intelligence in Epidemiology Revenue Market Share by Players (2020-2022)
3.2 Global Artificial Intelligence in Epidemiology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence in Epidemiology by Regions
4.1 Artificial Intelligence in Epidemiology Market Size by Regions (2017-2022)
4.2 Americas Artificial Intelligence in Epidemiology Market Size Growth (2017-2022)
4.3 APAC Artificial Intelligence in Epidemiology Market Size Growth (2017-2022)
4.4 Europe Artificial Intelligence in Epidemiology Market Size Growth (2017-2022)
4.5 Middle East & Africa Artificial Intelligence in Epidemiology Market Size Growth (2017-2022)
5 Americas
5.1 Americas Artificial Intelligence in Epidemiology Market Size by Country (2017-2022)
5.2 Americas Artificial Intelligence in Epidemiology Market Size by Type (2017-2022)
5.3 Americas Artificial Intelligence in Epidemiology Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence in Epidemiology Market Size by Region (2017-2022)
6.2 APAC Artificial Intelligence in Epidemiology Market Size by Type (2017-2022)
6.3 APAC Artificial Intelligence in Epidemiology Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence in Epidemiology by Country (2017-2022)
7.2 Europe Artificial Intelligence in Epidemiology Market Size by Type (2017-2022)
7.3 Europe Artificial Intelligence in Epidemiology Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence in Epidemiology by Region (2017-2022)
8.2 Middle East & Africa Artificial Intelligence in Epidemiology Market Size by Type (2017-2022)
8.3 Middle East & Africa Artificial Intelligence in Epidemiology Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence in Epidemiology Market Forecast
10.1 Global Artificial Intelligence in Epidemiology Forecast by Regions (2023-2028)
10.1.1 Global Artificial Intelligence in Epidemiology Forecast by Regions (2023-2028)
10.1.2 Americas Artificial Intelligence in Epidemiology Forecast
10.1.3 APAC Artificial Intelligence in Epidemiology Forecast
10.1.4 Europe Artificial Intelligence in Epidemiology Forecast
10.1.5 Middle East & Africa Artificial Intelligence in Epidemiology Forecast
10.2 Americas Artificial Intelligence in Epidemiology Forecast by Country (2023-2028)
10.2.1 United States Artificial Intelligence in Epidemiology Market Forecast
10.2.2 Canada Artificial Intelligence in Epidemiology Market Forecast
10.2.3 Mexico Artificial Intelligence in Epidemiology Market Forecast
10.2.4 Brazil Artificial Intelligence in Epidemiology Market Forecast
10.3 APAC Artificial Intelligence in Epidemiology Forecast by Region (2023-2028)
10.3.1 China Artificial Intelligence in Epidemiology Market Forecast
10.3.2 Japan Artificial Intelligence in Epidemiology Market Forecast
10.3.3 Korea Artificial Intelligence in Epidemiology Market Forecast
10.3.4 Southeast Asia Artificial Intelligence in Epidemiology Market Forecast
10.3.5 India Artificial Intelligence in Epidemiology Market Forecast
10.3.6 Australia Artificial Intelligence in Epidemiology Market Forecast
10.4 Europe Artificial Intelligence in Epidemiology Forecast by Country (2023-2028)
10.4.1 Germany Artificial Intelligence in Epidemiology Market Forecast
10.4.2 France Artificial Intelligence in Epidemiology Market Forecast
10.4.3 UK Artificial Intelligence in Epidemiology Market Forecast
10.4.4 Italy Artificial Intelligence in Epidemiology Market Forecast
10.4.5 Russia Artificial Intelligence in Epidemiology Market Forecast
10.5 Middle East & Africa Artificial Intelligence in Epidemiology Forecast by Region (2023-2028)
10.5.1 Egypt Artificial Intelligence in Epidemiology Market Forecast
10.5.2 South Africa Artificial Intelligence in Epidemiology Market Forecast
10.5.3 Israel Artificial Intelligence in Epidemiology Market Forecast
10.5.4 Turkey Artificial Intelligence in Epidemiology Market Forecast
10.5.5 GCC Countries Artificial Intelligence in Epidemiology Market Forecast
10.6 Global Artificial Intelligence in Epidemiology Forecast by Type (2023-2028)
10.7 Global Artificial Intelligence in Epidemiology Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott Informatics
11.1.1 Abbott Informatics Company Information
11.1.2 Abbott Informatics Artificial Intelligence in Epidemiology Product Offered
11.1.3 Abbott Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Informatics Main Business Overview
11.1.5 Abbott Informatics Latest Developments
11.2 AdvancedMD
11.2.1 AdvancedMD Company Information
11.2.2 AdvancedMD Artificial Intelligence in Epidemiology Product Offered
11.2.3 AdvancedMD Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AdvancedMD Main Business Overview
11.2.5 AdvancedMD Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Artificial Intelligence in Epidemiology Product Offered
11.3.3 Agilent Technologies Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Allscripts Healthcare
11.4.1 Allscripts Healthcare Company Information
11.4.2 Allscripts Healthcare Artificial Intelligence in Epidemiology Product Offered
11.4.3 Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Allscripts Healthcare Main Business Overview
11.4.5 Allscripts Healthcare Latest Developments
11.5 Athenahealth
11.5.1 Athenahealth Company Information
11.5.2 Athenahealth Artificial Intelligence in Epidemiology Product Offered
11.5.3 Athenahealth Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Athenahealth Main Business Overview
11.5.5 Athenahealth Latest Developments
11.6 Autoscribe Informatics
11.6.1 Autoscribe Informatics Company Information
11.6.2 Autoscribe Informatics Artificial Intelligence in Epidemiology Product Offered
11.6.3 Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Autoscribe Informatics Main Business Overview
11.6.5 Autoscribe Informatics Latest Developments
11.7 Cerner Corporation
11.7.1 Cerner Corporation Company Information
11.7.2 Cerner Corporation Artificial Intelligence in Epidemiology Product Offered
11.7.3 Cerner Corporation Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Cerner Corporation Main Business Overview
11.7.5 Cerner Corporation Latest Developments
11.8 Change Healthcare
11.8.1 Change Healthcare Company Information
11.8.2 Change Healthcare Artificial Intelligence in Epidemiology Product Offered
11.8.3 Change Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Change Healthcare Main Business Overview
11.8.5 Change Healthcare Latest Developments
11.9 Cognizant
11.9.1 Cognizant Company Information
11.9.2 Cognizant Artificial Intelligence in Epidemiology Product Offered
11.9.3 Cognizant Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Cognizant Main Business Overview
11.9.5 Cognizant Latest Developments
11.10 CPSI
11.10.1 CPSI Company Information
11.10.2 CPSI Artificial Intelligence in Epidemiology Product Offered
11.10.3 CPSI Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 CPSI Main Business Overview
11.10.5 CPSI Latest Developments
11.11 CureMD Healthcare
11.11.1 CureMD Healthcare Company Information
11.11.2 CureMD Healthcare Artificial Intelligence in Epidemiology Product Offered
11.11.3 CureMD Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 CureMD Healthcare Main Business Overview
11.11.5 CureMD Healthcare Latest Developments
11.12 eClinicalWorks
11.12.1 eClinicalWorks Company Information
11.12.2 eClinicalWorks Artificial Intelligence in Epidemiology Product Offered
11.12.3 eClinicalWorks Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 eClinicalWorks Main Business Overview
11.12.5 eClinicalWorks Latest Developments
11.13 e-Mds Inc.
11.13.1 e-Mds Inc. Company Information
11.13.2 e-Mds Inc. Artificial Intelligence in Epidemiology Product Offered
11.13.3 e-Mds Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 e-Mds Inc. Main Business Overview
11.13.5 e-Mds Inc. Latest Developments
11.14 Epic Systems
11.14.1 Epic Systems Company Information
11.14.2 Epic Systems Artificial Intelligence in Epidemiology Product Offered
11.14.3 Epic Systems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Epic Systems Main Business Overview
11.14.5 Epic Systems Latest Developments
11.15 GE Healthcare
11.15.1 GE Healthcare Company Information
11.15.2 GE Healthcare Artificial Intelligence in Epidemiology Product Offered
11.15.3 GE Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 GE Healthcare Main Business Overview
11.15.5 GE Healthcare Latest Developments
11.16 Google
11.16.1 Google Company Information
11.16.2 Google Artificial Intelligence in Epidemiology Product Offered
11.16.3 Google Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Google Main Business Overview
11.16.5 Google Latest Developments
11.17 Graphcore
11.17.1 Graphcore Company Information
11.17.2 Graphcore Artificial Intelligence in Epidemiology Product Offered
11.17.3 Graphcore Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Graphcore Main Business Overview
11.17.5 Graphcore Latest Developments
11.18 Greenway Health
11.18.1 Greenway Health Company Information
11.18.2 Greenway Health Artificial Intelligence in Epidemiology Product Offered
11.18.3 Greenway Health Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Greenway Health Main Business Overview
11.18.5 Greenway Health Latest Developments
11.19 IBM
11.19.1 IBM Company Information
11.19.2 IBM Artificial Intelligence in Epidemiology Product Offered
11.19.3 IBM Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 IBM Main Business Overview
11.19.5 IBM Latest Developments
11.20 Intel
11.20.1 Intel Company Information
11.20.2 Intel Artificial Intelligence in Epidemiology Product Offered
11.20.3 Intel Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Intel Main Business Overview
11.20.5 Intel Latest Developments
11.21 InterSystems
11.21.1 InterSystems Company Information
11.21.2 InterSystems Artificial Intelligence in Epidemiology Product Offered
11.21.3 InterSystems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 InterSystems Main Business Overview
11.21.5 InterSystems Latest Developments
11.22 Kareo
11.22.1 Kareo Company Information
11.22.2 Kareo Artificial Intelligence in Epidemiology Product Offered
11.22.3 Kareo Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Kareo Main Business Overview
11.22.5 Kareo Latest Developments
11.23 Medhost
11.23.1 Medhost Company Information
11.23.2 Medhost Artificial Intelligence in Epidemiology Product Offered
11.23.3 Medhost Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Medhost Main Business Overview
11.23.5 Medhost Latest Developments
11.24 Meditech
11.24.1 Meditech Company Information
11.24.2 Meditech Artificial Intelligence in Epidemiology Product Offered
11.24.3 Meditech Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Meditech Main Business Overview
11.24.5 Meditech Latest Developments
11.25 Medtronic
11.25.1 Medtronic Company Information
11.25.2 Medtronic Artificial Intelligence in Epidemiology Product Offered
11.25.3 Medtronic Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Medtronic Main Business Overview
11.25.5 Medtronic Latest Developments
11.26 Micron Technology
11.26.1 Micron Technology Company Information
11.26.2 Micron Technology Artificial Intelligence in Epidemiology Product Offered
11.26.3 Micron Technology Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Micron Technology Main Business Overview
11.26.5 Micron Technology Latest Developments
11.27 Microsoft
11.27.1 Microsoft Company Information
11.27.2 Microsoft Artificial Intelligence in Epidemiology Product Offered
11.27.3 Microsoft Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.27.4 Microsoft Main Business Overview
11.27.5 Microsoft Latest Developments
11.28 NextGen Healthcare
11.28.1 NextGen Healthcare Company Information
11.28.2 NextGen Healthcare Artificial Intelligence in Epidemiology Product Offered
11.28.3 NextGen Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.28.4 NextGen Healthcare Main Business Overview
11.28.5 NextGen Healthcare Latest Developments
11.29 Nvidia
11.29.1 Nvidia Company Information
11.29.2 Nvidia Artificial Intelligence in Epidemiology Product Offered
11.29.3 Nvidia Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.29.4 Nvidia Main Business Overview
11.29.5 Nvidia Latest Developments
11.30 Optum Inc.
11.30.1 Optum Inc. Company Information
11.30.2 Optum Inc. Artificial Intelligence in Epidemiology Product Offered
11.30.3 Optum Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.30.4 Optum Inc. Main Business Overview
11.30.5 Optum Inc. Latest Developments
12 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Intelligence in Epidemiology Market Size 2017-2028
2.1.2 Artificial Intelligence in Epidemiology Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Artificial Intelligence in Epidemiology Segment by Type
2.2.1 Hardware Technology
2.2.2 Software Technology
2.3 Artificial Intelligence in Epidemiology Market Size by Type
2.3.1 Artificial Intelligence in Epidemiology Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Artificial Intelligence in Epidemiology Market Size Market Share by Type (2017-2022)
2.4 Artificial Intelligence in Epidemiology Segment by Application
2.4.1 Disease and Syndromic Surveillance
2.4.2 Infection Prediction and Forecasting
2.4.3 Immunization Information Systems
2.4.4 Public Sentiment Analysis
2.4.5 Environmental Impact Analysis
2.4.6 Drug Discovery, Safety, and Risk Analysis
2.4.7 Monitoring Population and Incidence
2.4.8 Knowledge Representation and Mass Notification
2.5 Artificial Intelligence in Epidemiology Market Size by Application
2.5.1 Artificial Intelligence in Epidemiology Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Artificial Intelligence in Epidemiology Market Size Market Share by Application (2017-2022)
3 Artificial Intelligence in Epidemiology Market Size by Player
3.1 Artificial Intelligence in Epidemiology Market Size Market Share by Players
3.1.1 Global Artificial Intelligence in Epidemiology Revenue by Players (2020-2022)
3.1.2 Global Artificial Intelligence in Epidemiology Revenue Market Share by Players (2020-2022)
3.2 Global Artificial Intelligence in Epidemiology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence in Epidemiology by Regions
4.1 Artificial Intelligence in Epidemiology Market Size by Regions (2017-2022)
4.2 Americas Artificial Intelligence in Epidemiology Market Size Growth (2017-2022)
4.3 APAC Artificial Intelligence in Epidemiology Market Size Growth (2017-2022)
4.4 Europe Artificial Intelligence in Epidemiology Market Size Growth (2017-2022)
4.5 Middle East & Africa Artificial Intelligence in Epidemiology Market Size Growth (2017-2022)
5 Americas
5.1 Americas Artificial Intelligence in Epidemiology Market Size by Country (2017-2022)
5.2 Americas Artificial Intelligence in Epidemiology Market Size by Type (2017-2022)
5.3 Americas Artificial Intelligence in Epidemiology Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence in Epidemiology Market Size by Region (2017-2022)
6.2 APAC Artificial Intelligence in Epidemiology Market Size by Type (2017-2022)
6.3 APAC Artificial Intelligence in Epidemiology Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence in Epidemiology by Country (2017-2022)
7.2 Europe Artificial Intelligence in Epidemiology Market Size by Type (2017-2022)
7.3 Europe Artificial Intelligence in Epidemiology Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence in Epidemiology by Region (2017-2022)
8.2 Middle East & Africa Artificial Intelligence in Epidemiology Market Size by Type (2017-2022)
8.3 Middle East & Africa Artificial Intelligence in Epidemiology Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence in Epidemiology Market Forecast
10.1 Global Artificial Intelligence in Epidemiology Forecast by Regions (2023-2028)
10.1.1 Global Artificial Intelligence in Epidemiology Forecast by Regions (2023-2028)
10.1.2 Americas Artificial Intelligence in Epidemiology Forecast
10.1.3 APAC Artificial Intelligence in Epidemiology Forecast
10.1.4 Europe Artificial Intelligence in Epidemiology Forecast
10.1.5 Middle East & Africa Artificial Intelligence in Epidemiology Forecast
10.2 Americas Artificial Intelligence in Epidemiology Forecast by Country (2023-2028)
10.2.1 United States Artificial Intelligence in Epidemiology Market Forecast
10.2.2 Canada Artificial Intelligence in Epidemiology Market Forecast
10.2.3 Mexico Artificial Intelligence in Epidemiology Market Forecast
10.2.4 Brazil Artificial Intelligence in Epidemiology Market Forecast
10.3 APAC Artificial Intelligence in Epidemiology Forecast by Region (2023-2028)
10.3.1 China Artificial Intelligence in Epidemiology Market Forecast
10.3.2 Japan Artificial Intelligence in Epidemiology Market Forecast
10.3.3 Korea Artificial Intelligence in Epidemiology Market Forecast
10.3.4 Southeast Asia Artificial Intelligence in Epidemiology Market Forecast
10.3.5 India Artificial Intelligence in Epidemiology Market Forecast
10.3.6 Australia Artificial Intelligence in Epidemiology Market Forecast
10.4 Europe Artificial Intelligence in Epidemiology Forecast by Country (2023-2028)
10.4.1 Germany Artificial Intelligence in Epidemiology Market Forecast
10.4.2 France Artificial Intelligence in Epidemiology Market Forecast
10.4.3 UK Artificial Intelligence in Epidemiology Market Forecast
10.4.4 Italy Artificial Intelligence in Epidemiology Market Forecast
10.4.5 Russia Artificial Intelligence in Epidemiology Market Forecast
10.5 Middle East & Africa Artificial Intelligence in Epidemiology Forecast by Region (2023-2028)
10.5.1 Egypt Artificial Intelligence in Epidemiology Market Forecast
10.5.2 South Africa Artificial Intelligence in Epidemiology Market Forecast
10.5.3 Israel Artificial Intelligence in Epidemiology Market Forecast
10.5.4 Turkey Artificial Intelligence in Epidemiology Market Forecast
10.5.5 GCC Countries Artificial Intelligence in Epidemiology Market Forecast
10.6 Global Artificial Intelligence in Epidemiology Forecast by Type (2023-2028)
10.7 Global Artificial Intelligence in Epidemiology Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott Informatics
11.1.1 Abbott Informatics Company Information
11.1.2 Abbott Informatics Artificial Intelligence in Epidemiology Product Offered
11.1.3 Abbott Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Informatics Main Business Overview
11.1.5 Abbott Informatics Latest Developments
11.2 AdvancedMD
11.2.1 AdvancedMD Company Information
11.2.2 AdvancedMD Artificial Intelligence in Epidemiology Product Offered
11.2.3 AdvancedMD Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AdvancedMD Main Business Overview
11.2.5 AdvancedMD Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Artificial Intelligence in Epidemiology Product Offered
11.3.3 Agilent Technologies Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Allscripts Healthcare
11.4.1 Allscripts Healthcare Company Information
11.4.2 Allscripts Healthcare Artificial Intelligence in Epidemiology Product Offered
11.4.3 Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Allscripts Healthcare Main Business Overview
11.4.5 Allscripts Healthcare Latest Developments
11.5 Athenahealth
11.5.1 Athenahealth Company Information
11.5.2 Athenahealth Artificial Intelligence in Epidemiology Product Offered
11.5.3 Athenahealth Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Athenahealth Main Business Overview
11.5.5 Athenahealth Latest Developments
11.6 Autoscribe Informatics
11.6.1 Autoscribe Informatics Company Information
11.6.2 Autoscribe Informatics Artificial Intelligence in Epidemiology Product Offered
11.6.3 Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Autoscribe Informatics Main Business Overview
11.6.5 Autoscribe Informatics Latest Developments
11.7 Cerner Corporation
11.7.1 Cerner Corporation Company Information
11.7.2 Cerner Corporation Artificial Intelligence in Epidemiology Product Offered
11.7.3 Cerner Corporation Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Cerner Corporation Main Business Overview
11.7.5 Cerner Corporation Latest Developments
11.8 Change Healthcare
11.8.1 Change Healthcare Company Information
11.8.2 Change Healthcare Artificial Intelligence in Epidemiology Product Offered
11.8.3 Change Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Change Healthcare Main Business Overview
11.8.5 Change Healthcare Latest Developments
11.9 Cognizant
11.9.1 Cognizant Company Information
11.9.2 Cognizant Artificial Intelligence in Epidemiology Product Offered
11.9.3 Cognizant Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Cognizant Main Business Overview
11.9.5 Cognizant Latest Developments
11.10 CPSI
11.10.1 CPSI Company Information
11.10.2 CPSI Artificial Intelligence in Epidemiology Product Offered
11.10.3 CPSI Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 CPSI Main Business Overview
11.10.5 CPSI Latest Developments
11.11 CureMD Healthcare
11.11.1 CureMD Healthcare Company Information
11.11.2 CureMD Healthcare Artificial Intelligence in Epidemiology Product Offered
11.11.3 CureMD Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 CureMD Healthcare Main Business Overview
11.11.5 CureMD Healthcare Latest Developments
11.12 eClinicalWorks
11.12.1 eClinicalWorks Company Information
11.12.2 eClinicalWorks Artificial Intelligence in Epidemiology Product Offered
11.12.3 eClinicalWorks Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 eClinicalWorks Main Business Overview
11.12.5 eClinicalWorks Latest Developments
11.13 e-Mds Inc.
11.13.1 e-Mds Inc. Company Information
11.13.2 e-Mds Inc. Artificial Intelligence in Epidemiology Product Offered
11.13.3 e-Mds Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 e-Mds Inc. Main Business Overview
11.13.5 e-Mds Inc. Latest Developments
11.14 Epic Systems
11.14.1 Epic Systems Company Information
11.14.2 Epic Systems Artificial Intelligence in Epidemiology Product Offered
11.14.3 Epic Systems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Epic Systems Main Business Overview
11.14.5 Epic Systems Latest Developments
11.15 GE Healthcare
11.15.1 GE Healthcare Company Information
11.15.2 GE Healthcare Artificial Intelligence in Epidemiology Product Offered
11.15.3 GE Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 GE Healthcare Main Business Overview
11.15.5 GE Healthcare Latest Developments
11.16 Google
11.16.1 Google Company Information
11.16.2 Google Artificial Intelligence in Epidemiology Product Offered
11.16.3 Google Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Google Main Business Overview
11.16.5 Google Latest Developments
11.17 Graphcore
11.17.1 Graphcore Company Information
11.17.2 Graphcore Artificial Intelligence in Epidemiology Product Offered
11.17.3 Graphcore Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Graphcore Main Business Overview
11.17.5 Graphcore Latest Developments
11.18 Greenway Health
11.18.1 Greenway Health Company Information
11.18.2 Greenway Health Artificial Intelligence in Epidemiology Product Offered
11.18.3 Greenway Health Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Greenway Health Main Business Overview
11.18.5 Greenway Health Latest Developments
11.19 IBM
11.19.1 IBM Company Information
11.19.2 IBM Artificial Intelligence in Epidemiology Product Offered
11.19.3 IBM Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 IBM Main Business Overview
11.19.5 IBM Latest Developments
11.20 Intel
11.20.1 Intel Company Information
11.20.2 Intel Artificial Intelligence in Epidemiology Product Offered
11.20.3 Intel Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Intel Main Business Overview
11.20.5 Intel Latest Developments
11.21 InterSystems
11.21.1 InterSystems Company Information
11.21.2 InterSystems Artificial Intelligence in Epidemiology Product Offered
11.21.3 InterSystems Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 InterSystems Main Business Overview
11.21.5 InterSystems Latest Developments
11.22 Kareo
11.22.1 Kareo Company Information
11.22.2 Kareo Artificial Intelligence in Epidemiology Product Offered
11.22.3 Kareo Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Kareo Main Business Overview
11.22.5 Kareo Latest Developments
11.23 Medhost
11.23.1 Medhost Company Information
11.23.2 Medhost Artificial Intelligence in Epidemiology Product Offered
11.23.3 Medhost Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Medhost Main Business Overview
11.23.5 Medhost Latest Developments
11.24 Meditech
11.24.1 Meditech Company Information
11.24.2 Meditech Artificial Intelligence in Epidemiology Product Offered
11.24.3 Meditech Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Meditech Main Business Overview
11.24.5 Meditech Latest Developments
11.25 Medtronic
11.25.1 Medtronic Company Information
11.25.2 Medtronic Artificial Intelligence in Epidemiology Product Offered
11.25.3 Medtronic Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Medtronic Main Business Overview
11.25.5 Medtronic Latest Developments
11.26 Micron Technology
11.26.1 Micron Technology Company Information
11.26.2 Micron Technology Artificial Intelligence in Epidemiology Product Offered
11.26.3 Micron Technology Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Micron Technology Main Business Overview
11.26.5 Micron Technology Latest Developments
11.27 Microsoft
11.27.1 Microsoft Company Information
11.27.2 Microsoft Artificial Intelligence in Epidemiology Product Offered
11.27.3 Microsoft Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.27.4 Microsoft Main Business Overview
11.27.5 Microsoft Latest Developments
11.28 NextGen Healthcare
11.28.1 NextGen Healthcare Company Information
11.28.2 NextGen Healthcare Artificial Intelligence in Epidemiology Product Offered
11.28.3 NextGen Healthcare Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.28.4 NextGen Healthcare Main Business Overview
11.28.5 NextGen Healthcare Latest Developments
11.29 Nvidia
11.29.1 Nvidia Company Information
11.29.2 Nvidia Artificial Intelligence in Epidemiology Product Offered
11.29.3 Nvidia Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.29.4 Nvidia Main Business Overview
11.29.5 Nvidia Latest Developments
11.30 Optum Inc.
11.30.1 Optum Inc. Company Information
11.30.2 Optum Inc. Artificial Intelligence in Epidemiology Product Offered
11.30.3 Optum Inc. Artificial Intelligence in Epidemiology Revenue, Gross Margin and Market Share (2020-2022)
11.30.4 Optum Inc. Main Business Overview
11.30.5 Optum Inc. Latest Developments
12 Research Findings and Conclusion
no record found